Company Integrated BioPharma, Inc. Other OTC
Equities
INBP
US45811V1052
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Contract Manufacturing
95.3
%
| 54 | 96.2 % | 48 | 95.3 % | -10.75% |
Other Nutraceutical Businesses
4.7
%
| 2 | 3.8 % | 2 | 4.7 % | +11.14% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
84.1
%
| 47 | 82.7 % | 43 | 84.1 % | -8.38% |
International
15.9
%
| 10 | 17.3 % | 8 | 15.9 % | -17.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Riva Sheppard
CEO | Chief Executive Officer | 57 | 01/91/01 |
Christina Kay
CEO | Chief Executive Officer | 54 | 01/94/01 |
Dina Masi
DFI | Director of Finance/CFO | 63 | 17/05/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Christina Kay
CEO | Chief Executive Officer | 54 | 01/94/01 |
Damon Desantis
BRD | Director/Board Member | 56 | 20/22/20 |
Eric Friedman
BRD | Director/Board Member | 76 | 04/20/04 |
Riva Sheppard
CEO | Chief Executive Officer | 57 | 01/91/01 |
Robert Canarick
BRD | Director/Board Member | 74 | 01/94/01 |
William Milmoe
BRD | Director/Board Member | 76 | 18/08/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 30,134,510 | 6,092,115 ( 20.22 %) | 34,900 ( 0.1158 %) | 20.22 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |